SINAPPS Group

The SINAPPS group is a collaborative research team that studies the role of autoantibodies in psychosis.

[SINAPPS Group @SINAPPS_group]

A reminder that we have migrated to Bluesky!

Please find us there @sinappsgroup.bsky.social for all updates on the SINAPPS Group's research on autoantibodies in psychosis 🦋🦋🦋

[SINAPPS Group @SINAPPS_group]

After a snowy start to 2025, we are very happy to share we have now randomised our 53rd participant in SINAPPS2!

Here's to another year working towards better care and outcomes for all who experience symptoms of psychosis #Autoimmunity #Research

[SINAPPS Group @SINAPPS_group]

Great year for SINAPPS2 with 52 participants randomised!
With the help of our wonderful PPiP2 sites, it would be great to recruit a few more before the New Year!

[SINAPPS Group @SINAPPS_group]

The Annual Encephalitis International Conference is coming up soon! 2-3rd December 2024!

[SINAPPS Group @SINAPPS_group]

Thrilled to have randomised our 50th trial participant this week!! #Research

[SINAPPS Group @SINAPPS_group]

On #WorldMentalHeathDay we would like to extend a huge thank you to all patients, families, clinicians and others who give their time to research ⭐️🧠 this is hugely important in improving our understanding of mental health - thank you!

[SINAPPS Group @SINAPPS_group]

Shaking off the cobwebs and looking forward to seeing more PPiP2 recruitment numbers after the Summer break! Lots of new researchers trained 👍👍👍

[SINAPPS Group @SINAPPS_group]

Delighted that we randomised our 47th trial participant last week!! #research

[SINAPPS Group @SINAPPS_group]

Huge congratulations to our Oxford and Central North West London PPiP2 sites for their excellent recruitment in June! 🤩🤩

[SINAPPS Group @SINAPPS_group]

Great to see PUMA Early Psychosis project team meeting! Exciting!

[Oxford Psychiatry @OxPsychiatry]

The PUMA Early Psychosis project team gathered in London last week.

Funded @wellcometrust, supported @MQmentalhealth PUMA will develop a multi-arm, multi-stage trial platform, with the first trial due in 2027.

Thanks to all for the valuable discussions.

https://t.co/LHn4nHFXZG

[SINAPPS Group @SINAPPS_group]

Thank you to everyone who attended our All Sites Meeting on May 23rd, it was great to see you all and share recruitment ideas and strategies in this final year! To those who couldn't make it, video available very soon! #research

[SINAPPS Group @SINAPPS_group]

Our lovely team at the Department of Psychiatry Away Day!

Lots of exciting research into autoimmune psychosis taking place in Oxford, and across the U.K.!

[Oxford Psychiatry @OxPsychiatry]

The PUMA project is recruiting clinicians from Early Intervention in Psychosis teams to work on the design & setup of a new platform.

PUMA is developing a multi-arm multi-stage platform for clinical trials into early psychosis.

Deadline: Friday, May 17
https://t.co/9RIFiz3gla

[SINAPPS Group @SINAPPS_group]

Deadline approaching for this opportunity! @rcpsych

[SINAPPS Group @SINAPPS_group]

An exciting opportunity for Early Intervention clinicians! Closing date 17th May! 🏃‍♀️🏃
https://t.co/uFFLX4vuVK

[SINAPPS Group @SINAPPS_group]

Fascinating article ⬇️
https://t.co/YYsK25DdiF

[SINAPPS Group @SINAPPS_group]

An exciting opportunity for Early Intervention clinicians! Closing date 17th May! 🏃‍♀️🏃
https://t.co/uFFLX4vuVK

[Monty Lyman @monty_lyman]

The Immune Mind aims to showcase exciting new research revealing new roads between mind and body. My first shout out goes to the great scientists at my own department (@OxPsychiatry) exploring how antibodies affect mental health: @BLennox4 @SINAPPS_group

[SINAPPS Group @SINAPPS_group]

Thrilled with this new publication showcasing new research on the relationship between mind and body, by the very talented @monty_lyman in @OxPsychiatry! 🤩🤩

[SINAPPS Group @SINAPPS_group]

Excellent opportunity! #Research

[Oxford Psychiatry @OxPsychiatry]

People w/ lived experience of #psychosis & their carers are invited to join the PUMA project with @MQmentalhealth.

PUMA will involve the creation of a new clinical trial platform, aiming to speed up the discovery of effective treatments.

More👇
https://t.co/fzIH1azcGj

[SINAPPS Group @SINAPPS_group]

A huge congratulations to @johnheadleyward for winning a prize for his poster and Data Blitz presentation - fascinating insights into both the value and limitations of a liaison neurology service in a psychiatry setting. Superb work #BNPA24 @The_BNPA